Source: Annual Congress 2001 - Inflammation, infection and exercise capacity in cystic fibrosis patients
Disease area: Paediatric lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. Romano, R. Casciaro, I. Negro, N. Minuto, L. J. Galietta, O. Zegarra-Moran (Genova, Italy). Response to isoprenaline at nasal potential difference measurement and clinical variability in ΔF508 homozygote Cystic Fibrosis patients. Eur Respir J 2001; 16: Suppl. 31, 852

Member's Comments

No comment yet.

Related content which might interest you: Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002 Evaluation of the effectiveness of cyclical and constant current on sweat volume and stimulation for cystic fibroses diagnoses Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Nasal potential difference measurements in patients with atypical cystic fibrosis Source: Eur Respir J 2001; 17: 1208-1215 Year: 2001 Lung clearance Index changes over time among patients with cystic fibrosis Source: International Congress 2015 – New findings in paediatric respiratory physiology Year: 2015 Ability of lung clearance index to track changes in a routine clinical CF setting Source: International Congress 2015 – Paediatric respiratory physiology Year: 2015 Cystic Fibrosis: Clinical profile of 10 patients with R334W mutation compared to ?F508 homozigoty Source: Virtual Congress 2020 – Cystic fibrosis Year: 2020 Clinical value of lung clearance index (LCI) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Lung Clearance Index (LCI) and FEV1 on the evaluation of the effect of tobramycin solution for inhalation (TIS) among patients with cystic fibrosis Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment Year: 2014 Annual change of LCI among patients with cystic fibrosis Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017 Year: 2017 Changes in the Lung Clearance Index outside 15% are clinically relevant in children with cystic fibrosis Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis Year: 2021 Exercise improvements in ivacaftor treated G551D cystic fibrosis patients are not solely related to FEV1 and sweat changes Source: International Congress 2015 – Cystic fibrosis: physiology, biomarkers, microbiology and miscellaneous Year: 2015 Increased ventilation inhomogeneity in infants with Cystic Fibrosis (CF) Source: Eur Respir J 2002; 20: Suppl. 38, 209s Year: 2002 Side effects of inhaled tobramycin in patients with Cystic Fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 526s Year: 2002 The effect of Simeox airway clearance technology on resting hyperinflation in Cystic fibrosis patients Source: Virtual Congress 2020 – New insights into respiratory physiotherapy Year: 2020 Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016 Is Pulmonary Medication Adherence affected by disease severity among adult patients with Cystic Fibrosis? Source: Virtual Congress 2020 – Clinical monitoring and new therapies for cystic fibrosis Year: 2020 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Evaluation of annual FEV1 decline and factors associated with its accelerated deterioration in a cohort of adults with cystic fibrosis Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013